drugset / Trial / NCT01436110

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

NCT01436110

Phase 3 Completed 351 enrolled GlaxoSmithKline
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomised, double-blind, double-dummy, placebo controlled multi-centre study to evaluate the efficacy and safety of fluticasone furoate inhalation powder and fluticasone propionate inhalation powder in the treatment of asthma in adults and adolescents not currently treated with inhaled corticosteroids

Timeline

Start
2011-09
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Furoate Other / unclassified 50 ug Inhaled
Comparator Fluticasone propionate Other / unclassified 100 ug Inhaled

Indications